Here is the synopsis of our sample research paper on Generics, Ethics, and Law in the Pharmaceutical Industry. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 14 page discussion of the pharmaceutical industry and the reception generic drugs have within that industry. This paper presents the thesis that it is both ethical and legal for pharmaceutical companies to interfere with or to delay generic drugs being released into the marketplace. Bibliography lists 6 sources.
Page Count:
14 pages (~225 words per page)
File: AM2_PPmedDrugGenerics.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
that the pharmaceutical industry is a dog-eat-dog world, a world where the rich continue to grow richer and the poor continue to pay for that growth. In reality, the
pharmaceutical industry is an industry with many costs as well as considerable profit. One of the primary threats to that profit is generic drugs, those drugs that are developed
typically by a second company after the first company has invested the resources needed to develop the initial, patented drug. Whether released by a competitor or the initial company
itself in an attempt to stay on the playing field, however, generics are a definite threat to company profitability because they are reputed to be as effective in treating illness
as the patented drug and they are sold for a fraction of the cost. Not surprisingly, pharmaceutical companies are often in legal battles with one another trying to dominate
the market for a particular drug. Big drug companies often try to interfere with other companys release of a generic drug and delay their own introduction of generics that
would compete with their big moneymakers. Critiques of big business contend that big pharmaceutical companies are wrong in this approach, that the public is the loser when the release
of a generic drug is thwarted. The thesis can be presented, however, that: it
is both ethical and legal for pharmaceutical companies to interfere with or to delay generic drugs being released into the marketplace.
Drug development, after all, is a risky business. It is a business where failure is as likely as success. In order to
...